Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Advances in cardiovascular system endocrine].

Chao-Shu Tang¹, Yong-Fen Qi

¹Department of Physiology and Pathophysiology, Peking University Health Science Center, Beijing 100083, China.

Sheng Li Ke Xue Jin Zhan [Progress in Physiology]

|April 19, 2007

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Intermedin Inhibits DNA Damage-Promoted Senescent Phenotype Transition of Vascular Smooth Muscle Cells in Aorta by Activating NAMPT/PARP1 in Mice.

Pharmaceuticals (Basel, Switzerland)·2025

Same author

Intermedin<sub>1</sub><sub>-</sub><sub>53</sub> improves aging-associated cardiac remodeling and dysfunction via mitochondrial SIRT3-mediated SOD2 deacetylation.

Journal of molecular and cellular cardiology·2025

Same author

Intermedin Alleviates Diabetic Cardiomyopathy by Up-Regulating CPT-1β through Activation of the Phosphatidyl Inositol 3 Kinase/Protein Kinase B Signaling Pathway.

Pharmaceuticals (Basel, Switzerland)·2024

Same author

Intermedin alleviates diabetic vascular calcification by inhibiting GLUT1 through activation of the cAMP/PKA signaling pathway.

Atherosclerosis·2023

Same author

A predictive model of response to metoprolol in children and adolescents with postural tachycardia syndrome.

World journal of pediatrics : WJP·2023

Same author

Intermedin Alleviates Vascular Calcification in CKD through Sirtuin 3-Mediated Inhibition of Mitochondrial Oxidative Stress.

Pharmaceuticals (Basel, Switzerland)·2022

New bioactive peptides from the cardiovascular system offer promising therapeutic strategies for heart disease. Understanding their diverse forms and functions is key to developing effective treatments.

Area of Science:

Cardiovascular Biology
Molecular Medicine
Peptidomics

Background:

Bioactive substances from heart and vascular cells are crucial for cardiovascular homeostasis.
Discovering novel bioactive peptides enhances understanding and clinical treatment of cardiovascular diseases.
Cardiovascular bioactive peptides exhibit diverse forms and functions.

Purpose of the Study:

To explore the multifaceted nature of bioactive peptides in the cardiovascular system.
To elucidate the factors contributing to the complexity of peptide functions.
To highlight the clinical potential of cardiovascular bioactive peptides.

Main Methods:

Analysis of peptide secretion from cardiovascular cells.
Investigation of peptide-receptor interactions and gene splicing.

Related Experiment Videos

Examination of peptide precursor processing and ligand-receptor promiscuity.

Main Results:

Bioactive peptides are vital for maintaining cardiovascular system balance.
Peptide function is influenced by receptor characteristics and gene expression.
Multifunctionality arises from precursor fragments and flexible ligand-receptor binding.

Conclusions:

Bioactive peptides represent a significant area for cardiovascular disease research.
Further study of peptide complexity can unlock new therapeutic avenues.
Targeting these peptides holds promise for preventing and treating cardiovascular conditions.